SCHEMBL23375007

SCHEMBL23375007

CCNC(CO)C(=O)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MME P08473 2/20 0.40
TGFBR1 P36897 1/20 0.39
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP2C9 P11712 2/20 0.36
ALDH1A1 P00352 1/20 0.36
THRB P10828 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 1/20 0.36
POLB P06746 1/20 0.35
ZDHHC7 Q9NXF8 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
ATM Q13315 1/20 0.33
BIRC2 Q13490 1/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
PDCD1 Q15116 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21309845 1.00 MME (0.40) MMETGFBR1CA1CA2SMN1; SMN2
SCHEMBL23374703 1.00 MME (0.40) MMETGFBR1CA1CA2SMN1; SMN2
SCHEMBL28004382 0.84 TGFBR1 (0.34) MMETGFBR1MGAMGAASI
SCHEMBL21261739 0.84 CAD (0.42) TGFBR1CYP2C9ALDH1A1CYP2C19HSD17B10
SCHEMBL7921333 0.84 CA1 (0.42) CA1CA2SMN1; SMN2POLBZDHHC7
SCHEMBL8245351 0.84 TGFBR1 (0.41) MMETGFBR1CA1CA2SMN1; SMN2
SCHEMBL10296136 0.84 CA1 (0.42) CA1CA2SMN1; SMN2POLBZDHHC7
SCHEMBL14872113 0.80 MME (0.39) MMETGFBR1CA1CA2SMN1; SMN2
SCHEMBL23374708 0.80 CA1 (0.35) MMECA1CA2SMN1; SMN2CYP2C9
SCHEMBL21548093 0.79 ITGA4 (0.36) TGFBR1CA1CA2CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021093817-A1 IMMUNOMODULATORY COMPOUNDS, COMPOSITION AND APPLICATION THEREOF 杭州和正医药有限公司 2021-05-20 WO disclosed